Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats

Fernández‐Quintero, Monica L.; Quoika, Patrick K.; Wedl, Florian S.; Seidler, Clarissa A.; Kroell, Katharina B; Loeffler, Johannes R.; Pomarici, Nancy D; Hoerschinger, Valentin J; Bujotzek, Alexander; Georges, Guy; Kettenberger, Hubert; Liedl, Klaus R.

doi:10.3389/fmolb.2022.864654

Front. Mol. Biosci.

2022

DOI: 10.3389/fmolb.2022.864654

|View full text |Cite

Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats

Monica L. Fernández‐Quintero

Patrick K. Quoika

Florian S. Wedl

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Book1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Novel Bio-Engineering Techniques for Construction of Next-Generation Monoclonal Antibodies in the Framework of Personalized Medicine

Barazesh,

Mohammadi,

Jalili

2024

Personalized Medicine - New Perspectives [Working Title]

View full text Add to dashboard Cite

Monoclonal antibodies (mAbs), belonging to the IgG subclass, are the most progressively growing biopharmaceutics with successful applications for the remediation of chronic disorders, including tumors, inflammatory diseases, and retinal neovascularization. Several engineered platforms have been developed recently for the construction of new generations of these recombinant proteins with improved affinity, improved antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) function, improved effector activity, and therapeutic properties. These include engineered antibody fusion proteins such as CAR-T and CAR-NK cells, immunotoxin, bispecific antibodies, antibody-cytokine, and drug-conjugated antibodies. This chapter discusses various bioengineering techniques, focusing on genetic and protein engineering methods. Besides, it describes the superiority and drawbacks of these technologies for monoclonal antibody production by considering stability, effectiveness, affinity, and bio-safety for human applications. There is still potential for developing a novel technique that is straightforward, rapid, and affordable while ensuring the stability and efficiency of these biotherapeutic agents in the framework of personalized medicine. Contribution of these novel techniques to develop antibodies for personalized medicine application is anticipated through the quick generation of individual-specific antibodies with better therapeutic efficacy, affinity, and stability as well as the development of combinatorial medications and innovative antibody delivery platforms.

show abstract

Novel Bio-Engineering Techniques for Construction of Next-Generation Monoclonal Antibodies in the Framework of Personalized Medicine

Barazesh,

Mohammadi,

Jalili

2024

Personalized Medicine - New Perspectives [Working Title]

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats

Cited by 1 publication

References 0 publications

Novel Bio-Engineering Techniques for Construction of Next-Generation Monoclonal Antibodies in the Framework of Personalized Medicine

Novel Bio-Engineering Techniques for Construction of Next-Generation Monoclonal Antibodies in the Framework of Personalized Medicine

Contact Info

Product

Resources

About